{
    "eid": "2-s2.0-84981502021",
    "title": "HLA-B*58:01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand",
    "cover-date": "2016-07-18",
    "subject-areas": [
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        }
    ],
    "keywords": [
        "Allopurinol",
        "DRESS",
        "Drug hypersensitivity",
        "HLA-B*58:01",
        "MPE",
        "SJS",
        "TEN",
        "Thai"
    ],
    "authors": [
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 58,
    "ref-count": 33,
    "ref-list": [
        "Delayed drug hypersensitivity: Models of T-cell stimulation",
        "Pharmacogenetics of cutaneous adverse drug reactions",
        "Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study",
        "HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese",
        "HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: An updated review",
        "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome",
        "Human leukocyte antigen (HLA) pharmacogenomic tests: Potential and pitfalls",
        "The DRESS syndrome: The great clinical mimicker",
        "HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population",
        "HLA alleles and hypersensitivity to carbamazepine: An updated systematic review with meta-analysis",
        "Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-b genotype and allopurinol dosing",
        "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
        "HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency",
        "Positive and negative associations of HLA class i alleles with allopurinol-induced SCARs in Koreans",
        "HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Genotyping for severe drug hypersensitivity",
        "Pharmacogenetics of allopurinol-making an old drug safer",
        "Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?",
        "Clinical application of pharmacogenomics: The example of HLA-based drug-induced toxicity",
        "A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs",
        "Allopurinol hypersensitivity syndrome in patients with hematological malignancies: Characteristics and clinical outcomes",
        null,
        "Drug hypersensitivity: Pharmacogenetics and clinical syndromes",
        "Pathogenesis of drug-induced exanthems",
        "HLA alleles and drug hypersensitivity reactions",
        "HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: Evidence for high risk of drug-induced hypersensitivity",
        "Clinical risk factors for adverse events in allopurinol users",
        "Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population",
        "Severe cutaneous adverse drug reactions: A clinicoepidemiological study",
        "Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation",
        "Indian J. Psychiatry",
        "Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ramathibodi Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}